(Q50559294)
Statements
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group (English)
M Dalmark
S B Gjedde
D Pedersen
E Sandberg
M Kjaer
H T Mouridsen
C Rose
O S Nielsen